Home » Stocks » IsoRay

IsoRay, Inc. (ISR)

Stock Price: $0.670 USD 0.010 (1.52%)
Updated Aug 4, 2020 4:00 PM EDT - Market closed
After-hours: $0.675 +0.005 (0.69%) Aug 4, 8:00 PM

Stock Price Chart

Key Info

Market Cap 45.33M
Revenue (ttm) 9.33M
Net Income (ttm) -3.35M
Shares Out 67.65M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 4, 2020
Last Price $0.670
Previous Close $0.660
Change ($) 0.010
Change (%) 1.52%
Day's Open 0.698
Day's Range 0.655 - 0.698
Day's Volume 161,375
52-Week Range 0.288 - 1.060

More Stats

Market Cap 45.33M
Enterprise Value 43.57M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 67.65M
Float 66.76M
EPS (basic) -0.05
EPS (diluted) -0.05
FCF / Share -0.06
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.53M
Short Ratio 3.85
Short % of Float 2.28%
Beta 1.82
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.86
PB Ratio 7.40
Revenue 9.33M
Operating Income -3.43M
Net Income -3.35M
Free Cash Flow -4.11M
Net Cash 1.76M
Net Cash / Share 0.03
Gross Margin 32.68%
Operating Margin -36.79%
Profit Margin -36.10%
FCF Margin -44.04%
ROA -21.95%
ROE -46.48%
ROIC -74.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$1.33*
(98.51% upside)
Low
1.00
Current: $0.670
High
1.75
Target: 1.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue7.315.924.764.774.614.224.535.075.245.29
Revenue Growth23.48%24.41%-0.17%3.54%9.17%-6.76%-10.76%-3.2%-0.89%-
Gross Profit3.051.840.840.130.17-0.200.150.701.160.73
Operating Income-5.25-6.73-6.31-5.08-4.34-4.59-4.07-3.60-2.96-4.01
Net Income-5.14-6.70-6.16-4.71-3.68-5.96-3.86-3.49-2.84-4.03
Shares Outstanding67.0455.1655.0255.0254.8842.6834.4228.6225.1322.96
Earnings Per Share-0.08-0.12-0.11-0.09-0.07-0.16-0.11-0.12-0.11-0.18
Operating Cash Flow-5.05-5.71-5.71-3.88-3.52-3.23-3.06-2.45-2.42-2.69
Capital Expenditures-0.41-0.34-0.54-0.48-0.13-0.02-0.01-0.06-0.14-0.02
Free Cash Flow-5.46-6.05-6.26-4.36-3.66-3.25-3.06-2.50-2.56-2.71
Cash & Equivalents5.513.619.1515.5419.8823.273.082.852.291.86
Total Debt---------0.18
Net Cash / Debt5.513.619.1515.5419.8823.273.082.852.291.68
Assets9.427.4612.2718.1023.0026.557.067.517.897.94
Liabilities1.742.431.671.702.222.591.691.691.441.75
Book Value7.685.0310.6016.4020.7823.965.375.826.456.20
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name IsoRay, Inc.
Country United States
Employees 43
CEO Lori A. Woods

Stock Information

Ticker Symbol ISR
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSEAMERICAN: ISR

Description

IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is headquartered in Richland, Washington.